| __timestamp | Alpine Immune Sciences, Inc. | Amicus Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 20717000 |
| Thursday, January 1, 2015 | 6844000 | 47269000 |
| Friday, January 1, 2016 | 8586000 | 71151000 |
| Sunday, January 1, 2017 | 6079000 | 88671000 |
| Monday, January 1, 2018 | 8362000 | 127200000 |
| Tuesday, January 1, 2019 | 9467000 | 169861000 |
| Wednesday, January 1, 2020 | 10899000 | 156407000 |
| Friday, January 1, 2021 | 14560000 | 192710000 |
| Saturday, January 1, 2022 | 17968000 | 213041000 |
| Sunday, January 1, 2023 | 22222000 | 275270000 |
Unleashing insights
In the competitive landscape of biotechnology, managing operational costs is crucial for sustained growth. Over the past decade, Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc. have demonstrated contrasting trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Amicus Therapeutics consistently outpaced Alpine Immune Sciences, with expenses peaking at nearly 13 times higher in 2023. This significant difference highlights Amicus's aggressive expansion and investment strategies. Meanwhile, Alpine Immune Sciences showed a steady increase, with a notable 872% rise from 2014 to 2023. These trends reflect each company's strategic priorities and market positioning. As the biotech sector continues to evolve, understanding these financial dynamics offers valuable insights into corporate strategies and future growth potential.
Comparing SG&A Expenses: Merck & Co., Inc. vs Amicus Therapeutics, Inc. Trends and Insights
Amgen Inc. or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing GSK plc and Alpine Immune Sciences, Inc.
Genmab A/S or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Alpine Immune Sciences, Inc.
Cost Management Insights: SG&A Expenses for TG Therapeutics, Inc. and Amicus Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Alpine Immune Sciences, Inc. or Ligand Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Soleno Therapeutics, Inc.
ADMA Biologics, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Perrigo Company plc or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Amicus Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Who Optimizes SG&A Costs Better? Amicus Therapeutics, Inc. or Wave Life Sciences Ltd.